Larken Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LARKEN LABS, and what generic and branded alternatives to LARKEN LABS drugs are available?
LARKEN LABS has four approved drugs.
Summary for Larken Labs
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 4 |
| NDAs: | 4 |
Drugs and US Patents for Larken Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Larken Labs Inc | BUTALBITAL AND ACETAMINOPHEN | acetaminophen; butalbital | TABLET;ORAL | 203484-002 | Dec 4, 2015 | AA | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Larken Labs Inc | DEXAMETHASONE | dexamethasone | TABLET;ORAL | 201270-001 | Jul 17, 2017 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Larken Labs | DOXYCYCLINE HYCLATE | doxycycline hyclate | TABLET;ORAL | 065287-001 | Feb 28, 2006 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Larken Labs Inc | ALLZITAL | acetaminophen; butalbital | TABLET;ORAL | 203484-001 | Dec 4, 2015 | AA | RX | No | Yes | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
